The Competition Tribunal dismissed a lawsuit by the laboratory Tecnofarma S.A. against the laboratory Sanofi Synthelabo Grupo Sanofi Aventis. The Tribunal considered that, from the tone of the letters sent by the defendant to the plaintiff, it emerges that said letters had the sole purpose of informing the plaintiff of the existence of patents N° 42,308 and N° 41,429, owned by Sanofi, and that if the plaintiff manufacture, imported or sold products infringing those patents, Sanofi would exercise all the corresponding legal actions. According to the Tribunal, this cannot be reproached from an antitrust point of view, since sending the letters, in absence of other actions by the defendant, is part of the legitimate protection of legally registered patents.
